Oak Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$893K
- Investors
-
2
Oak Therapeutics General Information
Description
Developer of orally dissolvable strip formulations designed to deliver active pharmaceutical ingredients. The company offers proprietary technology with high drug-loading capacity, controlled-release profiles, and customizable dosing, enabling healthcare providers to address swallowing difficulties, dosing variability, and privacy concerns across diverse patient populations, particularly children.
Contact Information
Website
www.oaktherapeutics.comCorporate Office
- 3695 Corte Cancion
- Thousand Oaks, CA 91360
- United States
Corporate Office
- 3695 Corte Cancion
- Thousand Oaks, CA 91360
- United States
Oak Therapeutics Timeline
Oak Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 01-Jan-2025 | $893K | Completed | Pre-Clinical Trials | ||
| 3. Grant | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jan-2022 | $217K | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Oak Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oak Therapeutics Patents
Oak Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230330036-A1 | Long acting, continuous oral release from oral dispersing strips (ods) addressing the need for high dosage of active ingredients | Inactive | 13-Apr-2022 | ||
| US-11185500-B2 | Multi-layered high dosage dissolvable film for oral administration | Active | 18-Jun-2017 | ||
| US-20200268646-A1 | Multi-layered high dosage dissolvable film for oral administration | Active | 18-Jun-2017 | A61K9/006 |
Oak Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oak Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| KU Innovation Park | Accelerator/Incubator |
Oak Therapeutics FAQs
-
When was Oak Therapeutics founded?
Oak Therapeutics was founded in 2013.
-
Where is Oak Therapeutics headquartered?
Oak Therapeutics is headquartered in Thousand Oaks, CA.
-
What is the size of Oak Therapeutics?
Oak Therapeutics has 7 total employees.
-
What industry is Oak Therapeutics in?
Oak Therapeutics’s primary industry is Drug Delivery.
-
Is Oak Therapeutics a private or public company?
Oak Therapeutics is a Private company.
-
What is Oak Therapeutics’s current revenue?
The current revenue for Oak Therapeutics is .
-
Who are Oak Therapeutics’s investors?
National Institutes of Health and KU Innovation Park have invested in Oak Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
